Nifekalant
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | IV |
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 130636-43-0 |
PubChem (CID) | 4486 |
ChemSpider | 4331 |
UNII | 5VZ7GZM43E |
Chemical and physical data | |
Formula | C19H27N5O5 |
Molar mass | 405.44 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Nifekalant (INN) is a class III antiarrhythmic agent approved in Japan for the treatment of arrhythmias and ventricular tachycardia.[1] It has the brand name Shinbit.
References
- ↑ Oyabe A, Sano H (February 2002). "Pharmacological and clinical profile of nifekalant (shinbit injection), a class III antiarrhythmic drug". Nippon Yakurigaku Zasshi. 119 (2): 103–9. doi:10.1254/fpj.119.103. PMID 11862758.
This article is issued from Wikipedia - version of the 6/6/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.